| Net Cash Provided by (Used in) Operating Activities |
$8,175,000 |
USD |
|
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Financing Activities |
$7,500,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$9,613,000 |
USD |
-517% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
12,222,881 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$17,373,000 |
USD |
-381% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$7,414,000 |
USD |
-77% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$541,000 |
USD |
-44% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$19,747,000 |
USD |
-30% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$23,211,000 |
USD |
-22% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
-100% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
-100% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$3,464,000 |
USD |
97% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$3,142,000 |
USD |
-35% |
Q3 2025 |
Q3 2025 |